Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Integrated Pharmacokinetics (PK)/Efficacy, Safety, and Immunogenicity Study to Demonstrate Similarity of JPB898, a Proposed Biosimilar to Nivolumab, to Opdivo® in Combination With Yervoy® [Phase 3]
Phase 3 trial evaluating JPB898, a nivolumab biosimilar, in combination with ipilimumab for melanoma, was terminated after an integrated PK/…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care
A completed clinical trial explores using artificial intelligence to help doctors identify skin conditions, including dermatitis and melanom…
-
CLINICAL_TRIALS trial_result · 2026-02-19Clinical Trial Update: Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection
This clinical trial update assesses the effectiveness and safety of combining dabrafenib with trametinib as adjuvant therapy for Chinese pat…
-
CLINICAL_TRIALS trial_result · 2026-02-18Clinical Trial Update: Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma [Phase 3]
Phase 3 clinical trial evaluating two sequencing strategies for BRAFV600-mutant stage III–IV melanoma: dabrafenib plus trametinib followed b…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multiple Resected Solid Tumors [Phase 1]
Phase I trial comparing HLX17 to Keytruda in multiple solid tumors to evaluate pharmacokinetics, preliminary efficacy, safety, and immunogen…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
This completed postmarketing prospective study evaluated the risk of herpetic infection in melanoma patients treated with IMLYGIC.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma [Phase 2]
A Phase 2 clinical trial evaluating multiple doses of RO7247669 in previously untreated unresectable or metastatic melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers [Phase 1]
Adaptimmune's Phase 1 trial of MAGE-A10 CAR T therapy for urothelial carcinoma, head and neck cancer, and melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran (RO7198457) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Participants With Previously Untreated Advanced Melanoma. [Phase 2]
A Phase 2 randomized study evaluates Autogene Cevumeran (RO7198457) plus pembrolizumab versus pembrolizumab alone in previously untreated ad…
-
CLINICAL_TRIALS trial_result · 2026-01-30Clinical Trial Update: X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma [Phase 1]
Phase 1 trial of X-ray psoralen activated cancer therapy across head and neck cancer, breast cancer, sarcoma, and melanoma; currently recrui…
-
CLINICAL_TRIALS trial_result · 2026-01-29Clinical Trial Update: UCDCC#272: IL-2, Radiotherapy, and Pembrolizumab in Patients Refractory to Checkpoint Blockade [Phase 1, Phase 2]
Phase 1/2 trial evaluating interleukin-2 with radiotherapy and pembrolizumab in patients refractory to checkpoint blockade; results have bee…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Modified Virus VSV-IFNbetaTYRP1 in Treating Patients With Stage III-IV Melanoma [Phase 1]
Phase 1 trial of the modified virus VSV-IFNbetaTYRP1 in stage III-IV melanoma was terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Pilot Study of Biomarkers of Response to Immune Checkpoint Blockade in Metastatic Melanoma
This is a completed pilot clinical trial assessing biomarkers of response to immune checkpoint blockade in metastatic melanoma. The study ai…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: The Use of Dendritic Cell/Tumor Hybridomas as a Novel Tumor Vaccine in Patients With Advance Melanoma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating a dendritic cell/tumor hybridoma vaccine for metastatic melanoma.
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies [Phase 4]
Phase 4 clinical trial evaluating safety and quality of life in elderly patients with advanced/metastatic cancer undergoing immunotherapy ha…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Molecular Characterization of Advanced Stage Melanoma by Blood Sampling [NA]
This clinical trial update notes that the molecular characterization study of metastatic melanoma using blood sampling has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors. [Phase 1]
A Phase 1 study evaluating DKY709 alone or in combination with PDR001 in patients with advanced solid tumors. The enrolled diseases include …
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma [Phase 2]
A Phase 2 clinical trial update for Botensilimab (AGEN1181) in advanced melanoma shows the study is ongoing with the status listed as active…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: IN10018 Monotherapy and Combination Therapy for Metastatic Melanoma [Phase 1]
Phase 1 trial update for IN10018 in metastatic melanoma, evaluating both monotherapy and combination therapy. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Intratumoral N17350 in Advanced Solid Tumors [Phase 1, Phase 2]
Update on the investigational intratumoral therapy N17350 being studied in advanced solid tumors in Phase 1 and Phase 2 trials, sponsored by…
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: Clinical Trial Evaluating the Biological Activity of a New Drug Identified as Prifetrastat (PF-07248144), Combined With Fulvestrant for the Treatment of Patients With Hormone Receptor Positive (HR+) and HER2 Negative (HER2-) Breast Cancer Extended to Other Organs. [Phase 2]
Phase 2 clinical trial evaluating Prifetrastat (PF-07248144) in combination with Fulvestrant for HR+/HER2- breast cancer. The study is plann…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Prospective Observational Study on Targeted Therapy for Unresectable or Metastatic BRAFV600E Mutant Melanoma Patients
This document reports the completion of a prospective observational study evaluating targeted therapy for unresectable or metastatic BRAFV60…
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain [Phase 2]
A Phase 2 trial evaluating low-dose ipilimumab in combination with pembrolizumab for metastatic melanoma with brain metastases has completed…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma [Phase 3]
Phase 3 trial evaluating adjuvant nivolumab plus relatlimab vs nivolumab alone after complete resection of stage III-IV melanoma was termina…
-
CLINICAL_TRIALS trial_result · 2026-01-07Clinical Trial Update: Pilot Study to Determine Pro-Inflammatory Cytokine Kinetics During Immune Checkpoint Inhibitor Therapy
A completed pilot trial evaluating pro-inflammatory cytokine kinetics during immune checkpoint inhibitor therapy. It explores inflammatory r…